search
Back to results

The Impact of Music Intervention on Sleep

Primary Purpose

Dementia

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
CoMPoSER intervention group
Sleep Education
Sponsored by
Rutgers, The State University of New Jersey
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Dementia focused on measuring Dementia

Eligibility Criteria

18 Years - 100 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria for persons living with dementia (PLWD): Age 60 and above Existing physician diagnosis of dementia or self-reported memory impairment and Clinical Dementia Rating Scale score of greater than 0.5, Score of >10 on the Insomnia Severity Index Stable dose of psychotropic medications Agreeing to wear an actiwatch for the duration of the study PLWD Exclusion Criteria: Hearing impairment Planned transition to a residential or institutional care facility in 3 months Presence of extrapyramidal symptoms or acute sleep disruption Bed bound Living in an alternative home setting (such as Assisted Living Community) Informal caregivers inclusion criteria: Age 18 and above. Providing at least 4 hours of daily care Living with PLWD Able to read and communicate in English

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Experimental

    Arm Label

    Sleep Education Group

    CoMPoSER Intervention Group

    Arm Description

    Participants in this group will receive sleep education.

    Participants in this group will use a mobile application that plays calming music personalized for sleep enhancement.

    Outcomes

    Primary Outcome Measures

    Acceptability
    At least 80% of the dyads will find the intervention acceptable

    Secondary Outcome Measures

    PLWD Objective Sleep Outcomes
    Compared to PLWD in the sleep education control group, PLWD in the CoMPoSER intervention will experience improved insomnia symptoms of sleep latency, sleep efficiency, wake after sleep onset, total sleep time measured via sleep diary and actigraphy.
    PLWD Subjective Sleep Outcomes
    Compared to PLWD in the sleep education control group, PLWD in the CoMPoSER intervention will experience improved sleep quality via self-report. The Pittsburgh Sleep Quality Index (PSQI) will be used to measure sleep quality. In scoring the PSQI, seven component scores are derived, each scored 0 (no difficulty) to 3 (severe difficulty). The component scores are summed to produce a global score (range 0 to 21). Higher scores indicate worse sleep quality.
    Caregiver Stress Outcome
    Compared to caregivers in the sleep education control group, caregivers in the CoMPoSER intervention will experience less perceived stress. The Perceived Stress Scale (PSS) will be used to assess perceived stress among caregivers. The PSS has 10 items. Individual scores on the PSS can range from 0 to 40 with higher scores indicating higher perceived stress.
    Caregiver Wellbeing Outcome (Burden)
    Compared to caregivers in the sleep education control group, caregivers in the CoMPoSER intervention will experience improved wellbeing (less burden). The Zarit Burden Scale will be used to assess caregiver wellbeing. The ZBI consists of 22 items rated on a 5-point Likert scale that ranges from 0 (never) to 4 (nearly always) with the sum of scores ranging between 0-88. Higher scores indicate greater burden/worse wellbeing.
    Caregiver Wellbeing Outcome (Depression)
    Compared to caregivers in the sleep education control group, caregivers in the CoMPoSER intervention will experience improved wellbeing (less depression). The Patient Health Questionnaire (PHQ-9) will be used to assess caregiver wellbeing (depression). The PHQ-9 consists of 9 items rated on a 4-point Likert scale that ranges from 0 (not at all) to 4 (nearly every day) with the sum of scores ranging between 0-27. Higher scores indicate greater depression/worse wellbeing.
    Stress Change
    Changes in diurnal salivary cortisol from baseline to 1 month will mediate the effect of CoMPoSER on insomnia symptoms in PLWD.

    Full Information

    First Posted
    September 26, 2023
    Last Updated
    October 12, 2023
    Sponsor
    Rutgers, The State University of New Jersey
    Collaborators
    National Institute on Aging (NIA)
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT06088810
    Brief Title
    The Impact of Music Intervention on Sleep
    Official Title
    The Impact of Music Intervention on Sleep: CoMPoSER Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    October 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    June 1, 2024 (Anticipated)
    Primary Completion Date
    August 1, 2026 (Anticipated)
    Study Completion Date
    August 1, 2026 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Rutgers, The State University of New Jersey
    Collaborators
    National Institute on Aging (NIA)

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    The primary purpose of this Stage 1b NIH-funded clinical trial (K23AG073618, PI Petrovsky) is to determine the efficacy of a 1-month music intervention (Calming Music Personalized for Sleep Enhancement in PeRsons living with Dementia, CoMPoSER) on health outcomes in 72 dyads (144 participants) of persons living with dementia (PLWD) and their caregivers (Stage 1b). The secondary purpose of this research project is to examine the mechanism of stress reduction and sustained effects of the music intervention on PLWD and caregiver well-being. We will evaluate the acceptability of the mobile application CoMPoSER in a pilot RCT and determine the impact of the mobile application CoMPoSER on PLWD (sleep latency, sleep efficiency, wake after sleep onset, total sleep time, sleep quality) and caregiver (perceived stress and well-being) outcomes.
    Detailed Description
    Aim 1: Evaluate the acceptability of the mobile application CoMPoSER in a pilot RCT. Aim 2: Determine the impact of the mobile application CoMPoSER on PLWD (sleep latency, sleep efficiency, wake after sleep onset, total sleep time, sleep quality) and caregiver (perceived stress and well-being) outcomes. Aim 3: Examine stress reduction as a mechanism of action measured via salivary cortisol by which 1-month long CoMPoSER intervention affects insomnia symptoms in PLWD. Aim 4: To determine the sustained (3 months) efficacy of CoMPoSER compared to control group on PLWD and caregiver health outcomes.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Dementia
    Keywords
    Dementia

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    The study will consist of 144 participants (72 dyads). Dyads will receive 4 weekly phone calls in addition to the baseline and post-intervention in-person home visits. Those receiving the CoMPoSER intervention will undergo the following components: A) relaxation techniques; B) meaningful and relaxing music playlist, tailored to PLWD preferred genre, and C) nighttime routine guidance. Those undergoing the attention control intervention will receive sleep education. The attention control design includes participants finding their own treatment if assigned to no-treatment group and higher study dropout rates.
    Masking
    InvestigatorOutcomes Assessor
    Allocation
    Randomized
    Enrollment
    144 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Sleep Education Group
    Arm Type
    Active Comparator
    Arm Description
    Participants in this group will receive sleep education.
    Arm Title
    CoMPoSER Intervention Group
    Arm Type
    Experimental
    Arm Description
    Participants in this group will use a mobile application that plays calming music personalized for sleep enhancement.
    Intervention Type
    Other
    Intervention Name(s)
    CoMPoSER intervention group
    Intervention Description
    Participants in the intervention will use a mobile application that plays calming music personalized for sleep enhancement, relaxation techniques and nighttime routine guidance.
    Intervention Type
    Other
    Intervention Name(s)
    Sleep Education
    Intervention Description
    Participants in this intervention will receive sleep education based on the NIH/NIA guide, which includes tips for getting a good night's sleep.
    Primary Outcome Measure Information:
    Title
    Acceptability
    Description
    At least 80% of the dyads will find the intervention acceptable
    Time Frame
    4 weeks
    Secondary Outcome Measure Information:
    Title
    PLWD Objective Sleep Outcomes
    Description
    Compared to PLWD in the sleep education control group, PLWD in the CoMPoSER intervention will experience improved insomnia symptoms of sleep latency, sleep efficiency, wake after sleep onset, total sleep time measured via sleep diary and actigraphy.
    Time Frame
    1 month, 3 months
    Title
    PLWD Subjective Sleep Outcomes
    Description
    Compared to PLWD in the sleep education control group, PLWD in the CoMPoSER intervention will experience improved sleep quality via self-report. The Pittsburgh Sleep Quality Index (PSQI) will be used to measure sleep quality. In scoring the PSQI, seven component scores are derived, each scored 0 (no difficulty) to 3 (severe difficulty). The component scores are summed to produce a global score (range 0 to 21). Higher scores indicate worse sleep quality.
    Time Frame
    1 month, 3 months
    Title
    Caregiver Stress Outcome
    Description
    Compared to caregivers in the sleep education control group, caregivers in the CoMPoSER intervention will experience less perceived stress. The Perceived Stress Scale (PSS) will be used to assess perceived stress among caregivers. The PSS has 10 items. Individual scores on the PSS can range from 0 to 40 with higher scores indicating higher perceived stress.
    Time Frame
    1 month, 3 months
    Title
    Caregiver Wellbeing Outcome (Burden)
    Description
    Compared to caregivers in the sleep education control group, caregivers in the CoMPoSER intervention will experience improved wellbeing (less burden). The Zarit Burden Scale will be used to assess caregiver wellbeing. The ZBI consists of 22 items rated on a 5-point Likert scale that ranges from 0 (never) to 4 (nearly always) with the sum of scores ranging between 0-88. Higher scores indicate greater burden/worse wellbeing.
    Time Frame
    1 month, 3 months
    Title
    Caregiver Wellbeing Outcome (Depression)
    Description
    Compared to caregivers in the sleep education control group, caregivers in the CoMPoSER intervention will experience improved wellbeing (less depression). The Patient Health Questionnaire (PHQ-9) will be used to assess caregiver wellbeing (depression). The PHQ-9 consists of 9 items rated on a 4-point Likert scale that ranges from 0 (not at all) to 4 (nearly every day) with the sum of scores ranging between 0-27. Higher scores indicate greater depression/worse wellbeing.
    Time Frame
    1 month, 3 months
    Title
    Stress Change
    Description
    Changes in diurnal salivary cortisol from baseline to 1 month will mediate the effect of CoMPoSER on insomnia symptoms in PLWD.
    Time Frame
    1 month

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    100 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria for persons living with dementia (PLWD): Age 60 and above Existing physician diagnosis of dementia or self-reported memory impairment and Clinical Dementia Rating Scale score of greater than 0.5, Score of >10 on the Insomnia Severity Index Stable dose of psychotropic medications Agreeing to wear an actiwatch for the duration of the study PLWD Exclusion Criteria: Hearing impairment Planned transition to a residential or institutional care facility in 3 months Presence of extrapyramidal symptoms or acute sleep disruption Bed bound Living in an alternative home setting (such as Assisted Living Community) Informal caregivers inclusion criteria: Age 18 and above. Providing at least 4 hours of daily care Living with PLWD Able to read and communicate in English
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Darina Petrovsky
    Phone
    848-932-6898
    Email
    darina.petrovsky@rutgers.edu
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Darina Petrovsky
    Organizational Affiliation
    Rutgers University
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    11602004
    Citation
    Vitiello MV, Borson S. Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment. CNS Drugs. 2001;15(10):777-96. doi: 10.2165/00023210-200115100-00004.
    Results Reference
    background
    PubMed Identifier
    34090233
    Citation
    Petrovsky DV, Ramesh P, McPhillips MV, Hodgson NA. Effects of music interventions on sleep in older adults: A systematic review. Geriatr Nurs. 2021 Jul-Aug;42(4):869-879. doi: 10.1016/j.gerinurse.2021.04.014. Epub 2021 Jun 2.
    Results Reference
    background
    PubMed Identifier
    35991172
    Citation
    Cheour S, Cheour C, Kilani C, Guemri A, Zineddine D, Khelifa R, Supriya R, Bragazzi NL, Cheour F, Baker JS, Gaied-Chortane S. Salivary Testosterone and Cortisol Levels in Tunisian Elderly Male Patients With Mild Alzheimer's Disease. Implications of Musical Therapy And/Or Physical Rehabilitation. Front Physiol. 2022 Aug 5;13:839099. doi: 10.3389/fphys.2022.839099. eCollection 2022.
    Results Reference
    background
    PubMed Identifier
    17348758
    Citation
    Takahashi T, Matsushita H. Long-term effects of music therapy on elderly with moderate/severe dementia. J Music Ther. 2006 Winter;43(4):317-33. doi: 10.1093/jmt/43.4.317.
    Results Reference
    background
    PubMed Identifier
    25037297
    Citation
    Gooneratne NS, Vitiello MV. Sleep in older adults: normative changes, sleep disorders, and treatment options. Clin Geriatr Med. 2014 Aug;30(3):591-627. doi: 10.1016/j.cger.2014.04.007. Epub 2014 Jun 12.
    Results Reference
    background
    PubMed Identifier
    24559816
    Citation
    Shum A, Taylor BJ, Thayala J, Chan MF. The effects of sedative music on sleep quality of older community-dwelling adults in Singapore. Complement Ther Med. 2014 Feb;22(1):49-56. doi: 10.1016/j.ctim.2013.11.003. Epub 2013 Nov 14.
    Results Reference
    background

    Learn more about this trial

    The Impact of Music Intervention on Sleep

    We'll reach out to this number within 24 hrs